Concepedia

Publication | Open Access

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia

DOIFull Paper Access

92

Citations

34

References

2015

Year

Yu‐Chou Tseng, Samuel K. Kulp, I‐Lu Lai, En‐Chi Hsu, Wei He, David E. Frankhouser, Pearlly S. Yan, Xiaokui Mo, Mark Bloomston, Gregory B. Lesinski,
JNCI Journal of the National Cancer Institute

Abstract

These findings support further investigation of AR-42 as part of a comprehensive therapeutic strategy for cancer cachexia.

References

YearCitations

Page 1